Scivita Medical Technology Co. and Boston Scientific Corporation, a leading global medical technology company, have joined hands again to sign an expanded strategic cooperation arrangement.

The introduction of iterative endoscopic technology has brought about a positive transformation in the field of endoscopy, making it an interventional tool that combines diagnosis and treatment. Single-use videoscopes are considered a solution to cross-infection in traditional endoscopy, making them a promising solution for the future medical endoscope market. The global market value of single-use videoscope was $0.5 billion in 2020, and is estimated to increase to $9.2 billion in 2030, according to Frost & Sullivan.

Under the arrangement, China-based startup Scivita Medical will expand its relationship with Boston Scientific for strategic co-development and global distribution activities. Such activities may include collaboration on the co-development of future endoscopic devices, and global distribution opportunities for Scivita Medical's single-use endoscope and imaging devices. It is expected that this expanded arrangement will help bring Scivita Medical products to more hospitals and patients throughout China and other global geographies.